Concepedia

Feng Peng

FP

65

Publications

4.7K

Citations

34

H-Index

2002

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Peking University

Sichuan University

Chinese Academy of Sciences

Shanghai Institute of Organic Chemistry

Feng Peng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, organic chemistry, and chemistry.

ORCID

Top concepts

Publications per year

2002–2025

65

Publications

65

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 568 citations

, , +10

General Principles and Strategies for Salting-Out Informed by the Hofmeister Series

Alan M. Hyde, Susan L. Zultanski, Jacob H. Waldman et al. · Organic Process Research & Development · 2017 · 480 citations

, , +18

Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer

Min Wang, Jun Liu, Yan Zhao et al. · Molecular Cancer · 2020 · 292 citations · Full text

Cu-Catalyzed Esterification Reaction via Aerobic Oxygenation and C–C Bond Cleavage: An Approach to α-Ketoesters

Chun Zhang, Feng Peng, Ning Jiao · Journal of the American Chemical Society · 2013 · 258 citations

, , +17

PdCl<sub>2</sub> and <i>N</i>‐Hydroxyphthalimide Co‐catalyzed CH Hydroxylation by Dioxygen Activation

Yuepeng Yan, Feng Peng, Qing‐Zhong Zheng et al. · Angewandte Chemie International Edition · 2013 · 220 citations

Rows per page

1–5 of 65